Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Gabrielson

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|March 14, 2008
DNA methylation markers and early recurrence in stage I lung cancerMalcolm V Brock, Craig M Hooker, Emi Ota-Machida, et al.
The Journal of Clinical Investigation|August 8, 2013
Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesisAnju Singh, Christine Happel, Soumen K Manna, et al.
Radiology|September 6, 2017
Added Value of Computer-aided CT Image Features for Early Lung Cancer Diagnosis with Small Pulmonary Nodules: A Matched Case-Control StudyPeng Huang, Seyoun Park, Rongkai Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2021
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeuticsDhiraj Kumar, Akhilesh Mishra, Ala Lisok, et al.
The Journal of Clinical Investigation|November 21, 2018
Peptide-based PET quantifies target engagement of PD-L1 therapeuticsDhiraj Kumar, Ala Lisok, Elyes Dahmane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2013
Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclinesJana Jeschke, Heather M O'Hagan, Wei Zhang, et al.
American Journal of Clinical Pathology|January 29, 2013
A broad survey of cathepsin K immunoreactivity in human neoplasmsGang Zheng, Guido Martignoni, Cristina Antonescu, et al.
Science Translational Medicine|October 28, 2011
Preclinical and clinical evaluation of intraductally administered agents in early breast cancerVered Stearns, Tsuyoshi Mori, Lisa K Jacobs, et al.
Epigenetics|May 19, 2015
Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancerMarilia Freitas Calmon, Jana Jeschke, Wei Zhang, et al.
Epigenetics|June 1, 2012
Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screenJana Jeschke, Leander Van Neste, Sabine C Glöckner, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|March 14, 2008
DNA methylation markers and early recurrence in stage I lung cancerMalcolm V Brock, Craig M Hooker, Emi Ota-Machida, et al.
The Journal of Clinical Investigation|August 8, 2013
Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesisAnju Singh, Christine Happel, Soumen K Manna, et al.
Radiology|September 6, 2017
Added Value of Computer-aided CT Image Features for Early Lung Cancer Diagnosis with Small Pulmonary Nodules: A Matched Case-Control StudyPeng Huang, Seyoun Park, Rongkai Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2021
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeuticsDhiraj Kumar, Akhilesh Mishra, Ala Lisok, et al.
The Journal of Clinical Investigation|November 21, 2018
Peptide-based PET quantifies target engagement of PD-L1 therapeuticsDhiraj Kumar, Ala Lisok, Elyes Dahmane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2013
Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclinesJana Jeschke, Heather M O'Hagan, Wei Zhang, et al.
American Journal of Clinical Pathology|January 29, 2013
A broad survey of cathepsin K immunoreactivity in human neoplasmsGang Zheng, Guido Martignoni, Cristina Antonescu, et al.
Science Translational Medicine|October 28, 2011
Preclinical and clinical evaluation of intraductally administered agents in early breast cancerVered Stearns, Tsuyoshi Mori, Lisa K Jacobs, et al.
Epigenetics|May 19, 2015
Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancerMarilia Freitas Calmon, Jana Jeschke, Wei Zhang, et al.
Epigenetics|June 1, 2012
Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screenJana Jeschke, Leander Van Neste, Sabine C Glöckner, et al.
Pageof 14